Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page updates to Revision: v3.0.2, replacing v3.0.1, signaling a patch release. The Back to Top navigation element has been removed, a small UI/navigation change.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for Durvalumab and Tremelimumab. However, several previous entries related to drug information and genetic disease resources have been removed.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.